Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis
Frits R. Rosendaal(Leiden University Medical Center), Gordon Lowe(University of Glasgow), Mark Woodward(UNSW Sydney), Martin Vessey(Primary Health Care), Ann Rumley, Eman F. El-Daly(University of Oxford), Frans M. Helmerhorst(Leiden University Medical Center)
Cited by 156
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
|The Lancet|2010|4.2k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k